Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates

H D Strickler1, P S Rosenberg, S S Devesa

  • 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Md 20852, USA.

JAMA
|February 5, 1998
PubMed
Abstract

Insights

Exposure to simian virus 40 (SV40)-contaminated poliovirus vaccine did not increase cancer risk. This study found no significant association between SV40 exposure and ependymomas, osteosarcomas, or mesotheliomas over 30 years later.

Area of Science:

  • Oncology
  • Virology
  • Epidemiology

Background:

  • Poliovirus vaccine administered between 1955-1963 contained simian virus 40 (SV40), a polyomavirus found in rare human tumors.
  • SV40 DNA has been detected in human ependymomas, osteosarcomas, and mesotheliomas.

Purpose of the Study:

  • To investigate the risk of ependymoma, osteosarcoma, and mesothelioma in individuals exposed to SV40-contaminated poliovirus vaccine during childhood.
  • To determine long-term cancer risks associated with SV40 exposure.

Main Methods:

  • Retrospective cohort study utilizing data from the Surveillance, Epidemiology, and End Results program and the Connecticut Tumor Registry.
  • Analysis of birth cohorts exposed to SV40-contaminated poliovirus vaccine (1947-1969) compared to unexposed cohorts (1964-1969).
  • Calculation of relative risk (RR) for specific cancers in exposed versus unexposed groups.

Main Results:

  • No significant elevation in ependymoma or other brain cancer rates was observed in SV40-exposed cohorts (RR, 1.06; 95% CI, 0.69-1.63 for infants; RR, 0.98; 95% CI, 0.57-1.69 for children).
  • Osteosarcoma incidence showed no association with SV40 exposure (RR, 0.87; 95% CI, 0.71-1.06 for infants; RR, 0.85; 95% CI, 0.59-1.22 for children).
  • Mesothelioma association was not statistically significant, though study cohorts have not yet reached peak incidence age.

Conclusions:

  • Over 30 years post-exposure, SV40-contaminated poliovirus vaccine is not linked to increased rates of ependymomas, other brain cancers, osteosarcomas, or mesotheliomas in the US.
  • The study provides reassurance regarding the long-term safety of individuals exposed to SV40-contaminated vaccines.

Related Concept Videos

Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...